Results 221 to 230 of about 130,730 (348)

The association of proton pump inhibitors and inflammatory bowel disease from the perspective of gut microbiota perturbation. [PDF]

NPJ Biofilms Microbiomes
Hu L, Lai C, Li Y, Sun R, Yang H, Liu X, Peng Y.   +6 more
europepmc   +1 more source

Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions

, 2022
Franciosi JP, Mougey EB, Dellon ES, C Gutierrez-Junquera, S Fernandez-Fernandez, Venkatesh RD, Gupta SK   +6 more
openalex   +1 more source

Controlled Photocatalytic Reduction of CO2 by Precise Atomic‐Level Interface Modification and Engineering of Silver Nanoclusters

Advanced Science, EarlyView.
Ag44 nanoclusters are anchored on the CdS surface via low‐temperature electrostatic deposition. This facilitated the directed migration of electrons at the interface, thereby effectively suppressing the hydrogen evolution reaction and promoting the highly selective reduction of CO2 to carbon monoxide (CO).
Hangmin Xu, Xiang Liu, Ganghua Zhou, Chuanzhou Bi, Qing Liu, Weiyi Jiang, Bin Wang, Xingwang Zhu, Paul K. Chu, Xiaozhi Wang   +9 more
wiley   +1 more source

Effect of Acupuncture on Pneumonia Risk in Stroke Patients using Proton Pump Inhibitors: A Retrospective Case-Control Study. [PDF]

Brain Behav
Wang S, Ou M, Ban H, Yin T, Meng Y, Sun S, Zhang L, Du Y.   +7 more
europepmc   +1 more source

Mo1061 Electrical Stimulation Therapy (EST) of the Lower Esophageal Sphincter (LES) is Successful in Treating GERD in Proton Pump Inhibitors (PPI) Incomplete Responders - Post-Hoc Analysis of Open-Label Prospective Trial

, 2012
Leonardo Rodríguez, Patricia Rodríguez, Beatriz Gómez, Juan Carlos Ayala, Jorge Saba, Alberto Perez Castilla, Galvao Neto Manoel, Edy Soffer   +7 more
openalex   +1 more source

Crossing the Blood–Brain Barrier with Molecularly Imprinted Polymeric Nanocarriers: An Emerging Frontier in Brain Disease Therapy

Advanced Science, EarlyView.
Molecularly imprinted polymeric nanocarriers (nanoMIPs) offer robust, antibody‐mimetic platforms to overcome the blood‐brain barrier. The article surveys nanoMIP design and ligand‐directed surface engineering that harness receptor‐mediated transcytosis, and highlights therapeutic and diagnostic applications in neurodegeneration, brain tumors and ...
Ranjit De, Shuliang Shi, Kyong‐Tai Kim
wiley   +1 more source

Proton Pump Inhibitor Use in Older Adult Patients with Multiple Chronic Conditions: Clinical Risks and Best Practices

Laura Condur, Sergiu Chirilă, Luana Alexandrescu, Mihaela Adela Iancu, Andrea Elena Neculau, Filip Vasile Berariu, Luigi Toma, Alina Doina Nicoara   +7 more
openalex   +1 more source

Assessing the Appropriateness of Proton Pump Inhibitor Use in Ambulatory Patients: Findings from a Single-Centre Retrospective Study [PDF]

Kittipak Jenghua, Khuanrudee Khuanching, Kridkanya Tepkumpuwanon, Watcharikar Klomlai   +3 more
openalex   +1 more source

Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence [PDF]

, 2017
Marina L. Maes, Danielle R. Fixen, Sunny A. Linnebur   +2 more
openalex   +1 more source

Electronic and Steric Tuning of Molecular Acidity toward Unified Models for Excited State Proton Transfer

Advanced Science, EarlyView.
Conventional excited‐state proton transfer (ESPT) theories explain the kinetics of fluorescent photoacids, but face challenges for weakly or nonfluorescent ones. This missing link is bridged by making and dissecting series of green fluorescent protein chromophore derivatives with varied photoacidities via strategic substitutions. Structure‐photoacidity
Cheng Chen, Ivan N. Myasnyanko, Mikhail S. Baranov, Chong Fang   +3 more
wiley   +1 more source